ProPhase Labs Inc. has disclosed that a previously sealed civil action under the False Claims Act, originally filed in 2023, has been unsealed by the United States District Court for the Eastern District of New York. The company stated it had no prior knowledge of the lawsuit until receiving notice of the unsealing on November 21, 2025. ProPhase Labs denies any wrongdoing and asserts that its laboratory and diagnostic operations adhere to strict regulatory and compliance standards. The company does not expect the litigation to impact its ongoing operations or services and intends to vigorously defend itself in the matter. All prior private disputes with the plaintiff were resolved and dismissed in 2024, and are separate from the current qui tam action.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-024988), on November 25, 2025, and is solely responsible for the information contained therein.
Comments